EN
HI

DIVI S LABORATORIES Share price

DIVISLAB

HealthcareLarge

6279.5

65.00 (1.05%)
NSE
BSE
Last updated on 16 May, 2025 | 15:53 IST
BUYSELL
Today's High

6323.00

Today's Low

6162.00

52 Week Low

3830.00

52 Week High

6323.00

The current prices are delayed, login to your account for live prices

Divi's Laboratories Chart

DIVI S LABORATORIES Fundamentals

P/E Ratio

80.44

P/B Ratio

11.72

Div. Yield

0.48

Sector P/E

41.98

Sector P/B

4.77

Sec. Div. Yield

0.33

DIVI S LABORATORIES Resistance and Support

Pivot 6212.5

Resistance

First Resistance

6261.5

Second Resistance

6308.5

Third Resistance

6357.5

Support

First Support

6165.5

Second Support

6116.5

Third Support

6069.5

DIVI S LABORATORIES Futures & Options

DIVISLAB-EQ

6279.5

65 (1.05%)

DIVI S LABORATORIES Option Chain

View Price, OI, Greeks & More...
View Allee

29MAY25

6296.5

53.00 (0.85%)

26JUN25

6327.5

55.00 (0.88%)

31JUL25

6367

49.00 (0.78%)

DIVISLAB|29MAY25 CE 6250.00

225

815 (3.76%)

DIVISLAB|29MAY25 PE 6300.00

205.15

-3925 (-16.06%)

DIVI S LABORATORIES Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    51.89%

    Mutual Fund

    11.89%

    Insurance

    7.66%

    Foreign Institutional Investors

    17.98%

    Domestic Institutional Investors

    1%

    Retail

    9.59%

    Others

    -0.01%

    Total Promoters
    MAR '24
    51.92%
    JUN '24
    51.9%
    SEP '24
    51.89%
    DEC '24
    51.89%

    DIVI S LABORATORIES Corporate Actions

    DateAgenda
    2025-05-17Audited Results & Dividend
    2025-02-03Quarterly Results
    DateEvent TypeAgenda
    2025-05-17Board MeetingAudited Results & Dividend
    2025-02-03Board MeetingQuarterly Results

    DIVI S LABORATORIES News

    Divi's Laboratories Q2 Results: PAT jumps 46% YoY to Rs 510 crore on forex gain

    Nov 09 2024 15:02:27
    Read More

    About DIVI S LABORATORIES AboutThe

    NSE : 10940  
    BSE : 532488  
    ISIN : INE361B01024  

    BRIEF HISTORYDivi's Laboratories Limited was incorporated on October 12 1990 asDivi's Research Centre Private Limited. Subsequently the name of theCompany was changed to Divi's Laboratories Private Limited on October26 1994 and was thereafter converted into a public limited Company onDecember 12 1994 and renamed as Divi's Laboratories Limited.The Company commenced its activities in 1991 as a research andconsultancy organisation for developing commercial processes for ActivePharmaceutical Ingredients ("API") and intermediates. The Company hasbeen operating its research facility called Divi's Research Centre("DRC") from 1991 from its premises at Sanathnagar Hyderabad. Since1992 DRC has been recognised as an 'R&D Centre' by the Department ofScientific and Industrial Research Government of India. The Companysupplied process technology on turnkey basis to several generic drugmanufacturing companies.During 1994 the Company entered into manufacturing operations for APIand intermediates. It set up a multi-purpose manufacturing facility ona 300 acre site located at village Lingojigudem Choutuppal MandalNalgonda District in Andhra Pradesh with a 1000 cubic meters ofreactor capacity and a second research facility. The Plant is locatedabout 55 kms from Hyderabad on Hyderabad - Vijayawada National Highway.This project was part funded by way of term loans from a consortium ofBanks/ Financial Institutions to the extent of Rs. 3178 Lacs. TheCompany also made a private placement of unsecured Fully ConvertibleDebentures ("FCDs") aggregating Rs.2027 Lacs which have since beenconverted into 2549027 Equity Shares of the Company. The projectcommenced commercial operations in October 1995 with production ofNaproxene and other APIs for the export markets.Thereafter the Company has been making several additions to itsproduct portfolio and currently manufactures over 60 products. Some ofthe main products include Naproxene Naproxene Sodium DextromethorphanHydrobromide Diltiazem CIS Lactum Imaging Agents viz. X-Ray contrastmedia in the generic product segment besides other Intermediates. TheCompany is also involved in custom synthesis of intermediates for thediscovery products of MNCs for clinical trials/ launch. The Company hasalso ventured into the field of peptides synthesis. It has alsocommenced research in the areas of nucleotides and caretenoids whichit believes holds significant future potential.The Company has received several awards for its export performancequality and R&D efforts and has been recognised as a 'Trading House" byDirector General of Foreign Trade Ministry of Commerce Government ofIndia. It has also received certifications for ISO-9001 ISO-9002ISO-14001 OHSAS-18001 WHO-GMP European Certificate of Suitability(CoS) and has filed 9 Drug Master Files ("DMF") with US-FDA and theEuropean Directorate. The Company's manufacturing facility has beensuccessfully inspected by the US-FDA in September 2000.As part of its plans to increase its manufacturing capacity theCompany is in the process of setting up a second manufacturing facilityat village Chippada under Bheemunipatnam Mandal VisakhapatnamDistrict Andhra Pradesh. The Company has acquired a site of around314.855 acres with ready basic infrastructure. It is in the process ofobtaining all the requisite approvals and the commercial production isexpected to commence at this facility by March 1 2003.

    DIVI S LABORATORIES Management

    NamePosition
    Dr. Ramesh B V Nimmagadda Non Exe.Chairman&Ind.Director
    Dr. Murali K Divi Managing Director
    Mr. Madhusudana Rao Divi Whole Time Director
    Dr. Kiran S Divi WholeTime Director & CEO
    Ms. Nilima Prasad Divi Whole Time Director
    Read More

    DIVI S LABORATORIES FAQs

    DIVI S LABORATORIES शेयर का खरीद मूल्य 6279.5 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    DIVI S LABORATORIES शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    DIVI S LABORATORIES शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 80.44 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    DIVI S LABORATORIES शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 11.72 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    DIVI S LABORATORIES शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.77 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    DIVI S LABORATORIES का मार्केट कैप 166700.99 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    DIVI S LABORATORIES शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 6323.00 और 3830.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    DIVI S LABORATORIES Share Key Metrics

    Volume
    5.56 L
    Market Cap
    166700.99 CR
    LTQ@LTP
    20@6279.50
    ATP
    6251.54
    Var Margin
    14.77 %
    Circuit Range
    5593.5-6835.5
    Delivery %
    66.06 %
    Value
    347.79 CR
    ASM/GSM
    No
    Market Lot
    1